---
schema_version: "secwatch.filing_event.v1"
accession: "0001079973-23-000298"
form_type: "8-K"
ticker: null
cik: "0001602078"
company_name: "Nemaura Medical Inc."
filed_at: "2023-03-09T23:59:59+00:00"
generated_at: "2026-06-18T07:03:59.420276+00:00"
event_type: "regulatory"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Nemaura Medical receives Nasdaq non-compliance notice for late 10-Q, regained compliance after filing

## Summary
- Nasdaq notified Nemaura on Feb 23, 2023 of failure to timely file Form 10-Q for quarter ended Dec 31, 2022.
- Company filed the overdue Form 10-Q on Feb 24, 2023.
- Nasdaq confirmed compliance on Feb 27, 2023 and closed the matter.
- Press release issued March 9, 2023 to disclose the notice and resolution.

## SEC filing metadata
- accession: 0001079973-23-000298
- form_type: 8-K
- cik: 0001602078
- company_name: Nemaura Medical Inc.
- filed_at: 2023-03-09T23:59:59+00:00
- event_type: regulatory
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 3.01, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1602078/000107997323000298/0001079973-23-000298-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1602078/000107997323000298/nmra_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001079973-23-000298
- JSON: https://secwatch.observer/filing/0001079973-23-000298.json
- Plain text: https://secwatch.observer/filing/0001079973-23-000298.txt

## Key facts
- Listing & Compliance Notices
  Nemaura Medical Inc. received a nasdaq noncompliance notice notice regarding late filing (rules 5250(c)(1)).
  - Exchange: nasdaq
  - Notice: noncompliance notice
  - Deficiency: late filing
  - Rules: 5250(c)(1)
  source text: February 23, 2023, the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notified Nemaura Medical Inc. (the “Company”) that it was not in compliance with Nasdaq’s continued listing requirements under Nasdaq Listing Rule 5250(c)(1) (the “Rule”) as a result of its failure to timely file its Quarterly Report on Form 10-Q for the quarter ended December 31, 2022 (the “Form 10-Q”). Subsequently, on February 24, 2023, the Company filed the Form 10-Q and regained compliance with the Rule. On February 27, 2023, the Company received a notice from Nasdaq that, based on the Form
  evidence_url: https://www.sec.gov/Archives/edgar/data/1602078/000107997323000298/0001079973-23-000298-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.